ArticleWorld journal of surgical oncology2021

Higher titer hepatitis B core antibody predicts a higher risk of liver metastases and worse survival in patients with colorectal cancer.

Ziyao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.